108 related articles for article (PubMed ID: 11383817)
1. Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model.
Boehle AS; Sipos B; Kliche U; Kalthoff H; Dohrmann P
Ann Thorac Surg; 2001 May; 71(5):1657-65. PubMed ID: 11383817
[TBL] [Abstract][Full Text] [Related]
2. Combretastatin A-4 prodrug: a potent inhibitor of malignant hemangioendothelioma cell proliferation.
Böhle AS; Leuschner I; Kalthoff H; Henne-Bruns D
Int J Cancer; 2000 Sep; 87(6):838-43. PubMed ID: 10956395
[TBL] [Abstract][Full Text] [Related]
3. Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model.
Boehle AS; Kurdow R; Schulze M; Kliche U; Sipos B; Soondrum K; Ebrahimnejad A; Dohrmann P; Kalthoff H; Henne-Bruns D; Neumaier M
Int J Cancer; 2001 Nov; 94(3):420-8. PubMed ID: 11745424
[TBL] [Abstract][Full Text] [Related]
4. Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo.
Boehle AS; Kurdow R; Boenicke L; Schniewind B; Faendrich F; Dohrmann P; Kalthoff H
Langenbecks Arch Surg; 2002 Oct; 387(5-6):234-9. PubMed ID: 12410360
[TBL] [Abstract][Full Text] [Related]
5. Retroviral endostatin gene transfer inhibits growth of human lung cancer in a murine orthotopic xenotransplant model.
Kurdow R; Boehle AS; Ruhnke M; Mendoza R; Boenicke L; Sipos B; Schniewind B; Dohrmann P; Kalthoff H
Langenbecks Arch Surg; 2003 Dec; 388(6):401-5. PubMed ID: 12898260
[TBL] [Abstract][Full Text] [Related]
6. Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines.
Nabha SM; Wall NR; Mohammad RM; Pettit GR; Al-Katib AM
Anticancer Drugs; 2000 Jun; 11(5):385-92. PubMed ID: 10912955
[TBL] [Abstract][Full Text] [Related]
7. Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer.
Kurdow R; Boehle AS; Haye S; Boenicke L; Schniewind B; Dohrmann P; Kalthoff H
Ann Thorac Surg; 2002 Mar; 73(3):905-10. PubMed ID: 11899199
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
Pettit GR; Lippert JW
Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
[TBL] [Abstract][Full Text] [Related]
9. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.
Perez-Soler R; Kemp B; Wu QP; Mao L; Gomez J; Zeleniuch-Jacquotte A; Yee H; Lee JS; Jagirdar J; Ling YH
Clin Cancer Res; 2000 Dec; 6(12):4932-8. PubMed ID: 11156254
[TBL] [Abstract][Full Text] [Related]
10. [Liposome formulations of combretastatin A4 and 4-arylcoumarin analog prodrugs: antitumor effect in the mouse model of breast cancer].
Mouseeva EV; Kuznetsova NR; Svirshchevskaia EV; Bovin NV; Sitnikov NC; Shavyrin AS; Beletskaia IP; Combes S; Fedorov AIu; Vodovozova EL
Biomed Khim; 2012; 58(3):326-38. PubMed ID: 22856138
[TBL] [Abstract][Full Text] [Related]
11. Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts.
Lev-Ari S; Starr A; Katzburg S; Berkovich L; Rimmon A; Ben-Yosef R; Vexler A; Ron I; Earon G
J Nutr Biochem; 2014 Aug; 25(8):843-50. PubMed ID: 24835302
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
[TBL] [Abstract][Full Text] [Related]
13. Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.
Anderson TM; Hess SD; Egilmez NK; Nwogu CE; Lenox JM; Bankert RB
J Cancer Res Clin Oncol; 2003 Oct; 129(10):565-8. PubMed ID: 12923636
[TBL] [Abstract][Full Text] [Related]
14. An improved orthotopic xenotransplant procedure for human lung cancer in SCID bg mice.
Boehle AS; Dohrmann P; Leuschner I; Kalthoff H; Henne-Bruns D
Ann Thorac Surg; 2000 Apr; 69(4):1010-5. PubMed ID: 10800785
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
Holwell SE; Cooper PA; Thompson MJ; Pettit GR; Lippert LW; Martin SW; Bibby MC
Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
[TBL] [Abstract][Full Text] [Related]
16. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.
Grosios K; Holwell SE; McGown AT; Pettit GR; Bibby MC
Br J Cancer; 1999 Dec; 81(8):1318-27. PubMed ID: 10604728
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C
J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711
[TBL] [Abstract][Full Text] [Related]
19. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
Dark GG; Hill SA; Prise VE; Tozer GM; Pettit GR; Chaplin DJ
Cancer Res; 1997 May; 57(10):1829-34. PubMed ID: 9157969
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
